Info

Panacea Pharmaceuticals, Inc. was founded in 1999 to discover, develop, and commercialize novel therapeutic and diagnostic products for cancer and diseases of the central nervous system and cancer. The Company's core technologies exploit changes in disease-relevant proteins by altered expression, post-translational modification, and functional variation. The Company also conducts research through Collaborative Research and other agreements with M.D. Anderson Cancer Center in Houston, Texas; Massachusetts Institute of Technology in Cambridge, Massachusetts; and Rhode Island Hospital/Brown University in Providence, Rhode Island where teams of researchers are continuing advances on the Company's core technologies.